Epstein Secrets

imes.corn/2020/11/24/world/sputnik-vaccine-russia.html> (11124, Kramer, 18.61M) reports the manufacturers of the "leading Russian vaccine candidate" Sputnik V "said on Tuesday that it showed an efficacy rate of 95 percent in preliminary results from a clinical trial, which would put it at the same level

Handling Of Flu Vaccine Program. A New York Times <https://www.nytimes.com/2020/11/24/world/asia/korea-flu-vaccine-coronavirus- scare.html> (11/24, Sang-Hun, Grady, 18.61M) analysis says that South Korea's scientists, in response to reports of deaths in people receiving the flu vaccine, "quickly determin

tgoing Trump Administration." While the New York Times (11/24, Kramer, 18.61M) reports the manufacturers of the "leading Russian vaccine candidate" Sputnik V "said on Tuesday that it showed an efficacy rate of 95 percent in preliminary results from a clinical trial, which would put it at the same level

in cases. NYTimes Analysis Highlights Public Health Lessons From South Korea's Successful Handling Of Flu Vaccine Program. A New York Times (11/24, Sang-Hun, Grady, 18.61M) analysis says that South Korea's scientists, in response to reports of deaths in people receiving the flu vaccine, "quickly determi

uced Batch Of Sputnik V. Reuters (5/20) reports that Brazilian pharmaceutical company Uniao Quimica "completed production of its first batch of the Sputnik V coronavirus vaccine with active ingredients and technology supplied by Russia." Russia's Gamaleya Institute "said it had seen to quality control

's current target of 24.4% below 2017 levels. NYTimes Analysis: North Korean Nuclear Program Here To Stay. The New York Times (5/20, Sanger, Broad, Sang-Hun, 20.6M) reports that North Korea's nuclear arsenal has doubled in the past four years, and is likely to stay as Pakistan's, another nuclear armed s